Waters (NYSE:WAT) Raised to Strong-Buy at Rothschild Redb

Key Points

• Waters (NYSE:WAT) has been upgraded to a strong-buy rating by Rothschild Redb, indicating a positive outlook for the stock.
• The current consensus rating for Waters is Moderate Buy, with a consensus target price of $381.63.
• Waters reported a quarterly earnings per share (EPS) of $2.95, exceeding analysts' expectations and reflecting an 8.8% increase in revenue year-over-year.

Waters (NYSE:WAT - Get Free Report) was upgraded by stock analysts at Rothschild Redb to a "strong-buy" rating in a report released on Wednesday,Zacks.com reports.

Several other equities research analysts have also commented on the stock. Wall Street Zen lowered shares of Waters from a "buy" rating to a "hold" rating in a research note on Saturday, July 26th. Bank of America raised their price objective on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Wells Fargo & Company reduced their target price on Waters from $330.00 to $315.00 and set an "equal weight" rating for the company in a report on Tuesday, August 5th. Weiss Ratings restated a "hold (c)" rating on shares of Waters in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the company a "hold" rating in a research note on Tuesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, Waters presently has a consensus rating of "Moderate Buy" and a consensus target price of $381.63.

Waters Price Performance

Shares of NYSE WAT opened at $327.96 on Wednesday. The stock's 50-day simple moving average is $298.31 and its 200-day simple moving average is $324.73. The firm has a market capitalization of $19.52 billion, a PE ratio of 29.57, a price-to-earnings-growth ratio of 2.97 and a beta of 1.04. Waters has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same period in the prior year, the company posted $2.63 earnings per share. The firm's quarterly revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, equities research analysts forecast that Waters will post 12.86 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Olde Wealth Management LLC purchased a new stake in shares of Waters during the 1st quarter worth $25,000. Zions Bancorporation National Association UT purchased a new position in Waters in the first quarter valued at about $28,000. IFP Advisors Inc lifted its position in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock valued at $30,000 after acquiring an additional 44 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Waters in the 1st quarter worth approximately $41,000. Finally, CYBER HORNET ETFs LLC purchased a new position in Waters in the 2nd quarter valued at approximately $53,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.